Information Technology Services
Compare Stocks
2 / 10Stock Comparison
IBEX vs CNXC
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
IBEX vs CNXC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Information Technology Services | Information Technology Services |
| Market Cap | $379M | $1.67B |
| Revenue (TTM) | $627M | $9.83B |
| Net Income (TTM) | $47M | $-1.28B |
| Gross Margin | 21.3% | 33.3% |
| Operating Margin | 9.2% | 6.2% |
| Forward P/E | 8.2x | 2.0x |
| Total Debt | $70M | $4.64B |
| Cash & Equiv. | $15M | $327M |
IBEX vs CNXC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| IBEX Limited (IBEX) | 100 | 141.3 | +41.3% |
| Concentrix Corporat… (CNXC) | 100 | 29.6 | -70.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IBEX vs CNXC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IBEX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.80
- Rev growth 9.8%, EPS growth 28.3%, 3Y rev CAGR 4.2%
- 82.5% 10Y total return vs CNXC's -63.2%
CNXC is the clearest fit if your priority is value and dividends.
- Lower P/E (2.0x vs 8.2x)
- 6.0% yield; 5-year raise streak; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.8% revenue growth vs CNXC's 2.2% | |
| Value | Lower P/E (2.0x vs 8.2x) | |
| Quality / Margins | 7.5% margin vs CNXC's -13.0% | |
| Stability / Safety | Beta 0.80 vs CNXC's 1.38, lower leverage | |
| Dividends | 6.0% yield; 5-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +8.7% vs CNXC's -50.0% | |
| Efficiency (ROA) | 16.4% ROA vs CNXC's -10.8%, ROIC 19.5% vs 5.6% |
IBEX vs CNXC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IBEX vs CNXC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
IBEX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CNXC is the larger business by revenue, generating $9.8B annually — 15.7x IBEX's $627M. IBEX is the more profitable business, keeping 7.5% of every revenue dollar as net income compared to CNXC's -13.0%. On growth, IBEX holds the edge at +16.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $627M | $9.8B |
| EBITDAEarnings before interest/tax | $76M | $773M |
| Net IncomeAfter-tax profit | $47M | -$1.3B |
| Free Cash FlowCash after capex | $32M | $572M |
| Gross MarginGross profit ÷ Revenue | +21.3% | +33.3% |
| Operating MarginEBIT ÷ Revenue | +9.2% | +6.2% |
| Net MarginNet income ÷ Revenue | +7.5% | -13.0% |
| FCF MarginFCF ÷ Revenue | +5.2% | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +16.8% | +4.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +21.9% | -14.9% |
Valuation Metrics
CNXC leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, CNXC's 4.7x EV/EBITDA is more attractive than IBEX's 6.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $379M | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $433M | $6.0B |
| Trailing P/EPrice ÷ TTM EPS | 11.91x | -1.17x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.23x | 2.03x |
| PEG RatioP/E ÷ EPS growth rate | 0.30x | — |
| EV / EBITDAEnterprise value multiple | 6.78x | 4.75x |
| Price / SalesMarket cap ÷ Revenue | 0.68x | 0.17x |
| Price / BookPrice ÷ Book value/share | 3.29x | 0.54x |
| Price / FCFMarket cap ÷ FCF | 13.87x | 2.91x |
Profitability & Efficiency
IBEX leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
IBEX delivers a 31.8% return on equity — every $100 of shareholder capital generates $32 in annual profit, vs $-33 for CNXC. IBEX carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNXC's 1.69x. On the Piotroski fundamental quality scale (0–9), IBEX scores 7/9 vs CNXC's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +31.8% | -33.2% |
| ROA (TTM)Return on assets | +16.4% | -10.8% |
| ROICReturn on invested capital | +19.5% | +5.6% |
| ROCEReturn on capital employed | +22.4% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.52x | 1.69x |
| Net DebtTotal debt minus cash | $54M | $4.3B |
| Cash & Equiv.Liquid assets | $15M | $327M |
| Total DebtShort + long-term debt | $70M | $4.6B |
| Interest CoverageEBIT ÷ Interest expense | 62.30x | -3.07x |
Total Returns (Dividends Reinvested)
IBEX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IBEX five years ago would be worth $11,977 today (with dividends reinvested), compared to $1,899 for CNXC. Over the past 12 months, IBEX leads with a +8.7% total return vs CNXC's -50.0%. The 3-year compound annual growth rate (CAGR) favors IBEX at 14.6% vs CNXC's -31.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -22.6% | -40.7% |
| 1-Year ReturnPast 12 months | +8.7% | -50.0% |
| 3-Year ReturnCumulative with dividends | +50.4% | -67.8% |
| 5-Year ReturnCumulative with dividends | +19.8% | -81.0% |
| 10-Year ReturnCumulative with dividends | +82.5% | -63.2% |
| CAGR (3Y)Annualised 3-year return | +14.6% | -31.4% |
Risk & Volatility
IBEX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IBEX is the less volatile stock with a 0.80 beta — it tends to amplify market swings less than CNXC's 1.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IBEX currently trades 65.4% from its 52-week high vs CNXC's 38.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.80x | 1.38x |
| 52-Week HighHighest price in past year | $42.99 | $62.14 |
| 52-Week LowLowest price in past year | $24.53 | $22.85 |
| % of 52W HighCurrent price vs 52-week peak | +65.4% | +38.2% |
| RSI (14)Momentum oscillator 0–100 | 50.5 | 36.5 |
| Avg Volume (50D)Average daily shares traded | 114K | 1.6M |
Analyst Outlook
CNXC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates IBEX as "Hold" and CNXC as "Buy". Consensus price targets imply 119.2% upside for CNXC (target: $52) vs -14.6% for IBEX (target: $24). CNXC is the only dividend payer here at 6.00% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $24.00 | $52.00 |
| # AnalystsCovering analysts | 6 | 9 |
| Dividend YieldAnnual dividend ÷ price | — | +6.0% |
| Dividend StreakConsecutive years of raises | 2 | 5 |
| Dividend / ShareAnnual DPS | — | $1.42 |
| Buyback YieldShare repurchases ÷ mkt cap | +20.6% | +11.3% |
IBEX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNXC leads in 2 (Valuation Metrics, Analyst Outlook).
IBEX vs CNXC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is IBEX or CNXC a better buy right now?
For growth investors, IBEX Limited (IBEX) is the stronger pick with 9.
8% revenue growth year-over-year, versus 2. 2% for Concentrix Corporation (CNXC). IBEX Limited (IBEX) offers the better valuation at 11. 9x trailing P/E (8. 2x forward), making it the more compelling value choice. Analysts rate Concentrix Corporation (CNXC) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IBEX or CNXC?
On forward P/E, Concentrix Corporation is actually cheaper at 2.
0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IBEX or CNXC?
Over the past 5 years, IBEX Limited (IBEX) delivered a total return of +19.
8%, compared to -81. 0% for Concentrix Corporation (CNXC). Over 10 years, the gap is even starker: IBEX returned +82. 5% versus CNXC's -63. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IBEX or CNXC?
By beta (market sensitivity over 5 years), IBEX Limited (IBEX) is the lower-risk stock at 0.
80β versus Concentrix Corporation's 1. 38β — meaning CNXC is approximately 73% more volatile than IBEX relative to the S&P 500. On balance sheet safety, IBEX Limited (IBEX) carries a lower debt/equity ratio of 52% versus 169% for Concentrix Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — IBEX or CNXC?
By revenue growth (latest reported year), IBEX Limited (IBEX) is pulling ahead at 9.
8% versus 2. 2% for Concentrix Corporation (CNXC). On earnings-per-share growth, the picture is similar: IBEX Limited grew EPS 28. 3% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, CNXC leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IBEX or CNXC?
IBEX Limited (IBEX) is the more profitable company, earning 6.
6% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IBEX leads at 8. 3% versus 6. 2% for CNXC. At the gross margin level — before operating expenses — CNXC leads at 35. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IBEX or CNXC more undervalued right now?
On forward earnings alone, Concentrix Corporation (CNXC) trades at 2.
0x forward P/E versus 8. 2x for IBEX Limited — 6. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNXC: 119. 2% to $52. 00.
08Which pays a better dividend — IBEX or CNXC?
In this comparison, CNXC (6.
0% yield) pays a dividend. IBEX does not pay a meaningful dividend and should not be held primarily for income.
09Is IBEX or CNXC better for a retirement portfolio?
For long-horizon retirement investors, IBEX Limited (IBEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
80)). Both have compounded well over 10 years (IBEX: +82. 5%, CNXC: -63. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IBEX and CNXC?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IBEX is a small-cap deep-value stock; CNXC is a small-cap income-oriented stock. CNXC pays a dividend while IBEX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.